Zhao H - Search Results

1

Classification of Tumor Immune Microenvironment According to Programmed Death-Ligand 1 Expression and Immune Infiltration Predicts Response to Immunotherapy Plus Chemotherapy in Advanced Patients With NSCLC.

Sun D, Liu J, Zhou H, Shi M, Sun J, Zhao S, Chen G, Zhang Y, Zhou T, Ma Y, Zhao Y, Fang W, Zhao H, Huang Y, Yang Y, Zhang L. Sun D, et al. Among authors: zhao h, zhao y, zhao s. J Thorac Oncol. 2023 Jul;18(7):869-881. doi: 10.1016/j.jtho.2023.03.012. Epub 2023 Mar 21. J Thorac Oncol. 2023. PMID: 36948245 Free article. Clinical Trial.

2

[Efficacy of gefitinib on Chinese patients with locally advanced or metastatic non-small cell lung cancer: a clinical trial].

Guan ZZ, Zhang L, Li LY, Jiang GL, Liu XY, Chu DT, Zhao HY, Li W. Guan ZZ, et al. Ai Zheng. 2005 Aug;24(8):980-4. Ai Zheng. 2005. PMID: 16086877 Clinical Trial. Chinese.

3

[Efficacy of gefitinib on advanced non-small cell lung cancer in expanded access program (EAP)].

Zhang Y, Zhang L, Xu F, Wang ZQ, Zhao HY, Guan ZZ, Xu GC, Pan ZK. Zhang Y, et al. Ai Zheng. 2006 Dec;25(12):1561-4. Ai Zheng. 2006. PMID: 17166387 Chinese.

4

[Efficacy of erlotinib on advanced non-small cell lung cancer].

Zhao HY, Zhang Y, Huang H, Chen LK, Xu GC, Zhang L. Zhao HY, et al. Ai Zheng. 2008 Apr;27(4):393-9. Ai Zheng. 2008. PMID: 18423126 Free article. Chinese.

5

Predictive significance of bone sialoprotein and osteopontin for bone metastases in resected Chinese non-small-cell lung cancer patients: a large cohort retrospective study.

Zhang L, Hou X, Lu S, Rao H, Hou J, Luo R, Huang H, Zhao H, Jian H, Chen Z, Liao M, Wang X. Zhang L, et al. Among authors: zhao h. Lung Cancer. 2010 Jan;67(1):114-9. doi: 10.1016/j.lungcan.2009.03.017. Lung Cancer. 2010. PMID: 19376608

6

[Analysis of the efficacy and safety of gefitinib in the treatment of recurrent advanced non-small cell lung cancer in an expanded access program (EAP)].

Huang H, Zhang Y, Zhao HY, Wang ZQ, Xu F, Xu GC, Zhang L, Guan ZZ. Huang H, et al. Among authors: zhao hy. Zhonghua Zhong Liu Za Zhi. 2009 Feb;31(2):148-51. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19538895 Chinese.

7

[Predictive factors for response and survival of gefitinib-treated locally advanced or metastatic non-small cell lung cancer patients: a retrospective analysis of two phase II clinical trials].

Zhao YY, Zhang Y, Zhao HY, Wu JX, Jiang W, Xue C, Zhang L. Zhao YY, et al. Ai Zheng. 2009 Jun;28(6):626-31. Ai Zheng. 2009. PMID: 19635201 Free article. Chinese.

8

Validation of a clinical prognostic model in Chinese patients with metastatic and advanced pretreated non-small cell lung cancer treated with gefitinib.

Wang F, Zhang Y, Zhao H, Chen L, Shi YX, Zhang L. Wang F, et al. Among authors: zhao h. Med Oncol. 2011 Mar;28(1):331-5. doi: 10.1007/s12032-010-9451-1. Epub 2010 Mar 4. Med Oncol. 2011. PMID: 20204544

9

The relationship between drug exposure and clinical outcomes of non-small cell lung cancer patients treated with gefitinib.

Zhao YY, Li S, Zhang Y, Zhao HY, Liao H, Guo Y, Shi YX, Jiang W, Xue C, Zhang L. Zhao YY, et al. Among authors: zhao hy. Med Oncol. 2011 Sep;28(3):697-702. doi: 10.1007/s12032-010-9541-0. Epub 2010 May 11. Med Oncol. 2011. PMID: 20458561 Clinical Trial.

10

[A prospective randomized study of the radiotherapy volume for limited-stage small cell lung cancer: a preliminary report].

Hu X, Bao Y, Zhang L, Cheng Y, Li K, Wang W, Liu Y, He H, Sun Z, Zhuang T, Wang Y, Chen J, Liang Y, Zhang Y, Zhao H, Wang F, Chen M. Hu X, et al. Among authors: zhao h. Zhongguo Fei Ai Za Zhi. 2010 Jul;13(7):691-9. doi: 10.3779/j.issn.1009-3419.2010.07.07. Zhongguo Fei Ai Za Zhi. 2010. PMID: 20673485 Free PMC article. Clinical Trial. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33,921 results

Search Page